Browse Category

Antibody Therapy News 14 November 2025

Invivyd (IVVD) Rockets Over 50% Pre‑Market on November 14, 2025 as Traders Rush Into COVID Antibody Play

Invivyd (IVVD) Rockets Over 50% Pre‑Market on November 14, 2025 as Traders Rush Into COVID Antibody Play

Invivyd, Inc. (NASDAQ: IVVD) is back in the spotlight this Friday, November 14, 2025, with its stock exploding higher in pre‑market trading on the back of building momentum around its COVID‑19 antibody franchise and recent earnings. By early morning, IVVD was one of the most actively watched biotech names on Wall Street. Invivyd stock today: IVVD among top pre‑market gainers Multiple market data sources show Invivyd staging a huge move before the opening bell: In short, Invivyd stock is up roughly 40–60% in Friday’s pre‑market session, depending on the venue and timestamp, after closing at $1.77 on November 13. Notably,
14 November 2025
Go toTop